H.R. 6813 · 117th Congress
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes…
Full title
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
KeatingSponsorNo cosponsors.
This bill requires the National Institutes of Health to study and report on the neurological impacts of COVID-19 on individuals with a neurological disease.
What it does: CRS summary · Introduced in House · Feb 22, 2022
This bill requires the National Institutes of Health to study and report on the neurological impacts of COVID-19 on individuals with a neurological disease.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Latest action (Feb 23, 2022): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Feb 22, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.